Morphosys sees over $1 billion in sales from MOR 103: CEO

FRANKFURT (Reuters) - German biotech company Morphosys expects its upcoming rheumatism drug MOR 103 to generate sales of more than $1 billion per year, if it succeeds in getting marketing approvals, its chief executive told Reuters. "The mark...

Source: http://health.yahoo.net/news/s/nm/morphosys-sees-over-1-billion-in-sales-from-mor-103-ceo

Jesus Receipt design John Edwards Jorja Fox